REGISTERED
on 09 Oct 2019
Last Applicant/ Owned by
Chuo-ku, Kobe-shi Hyogo 650-0047
JP
Serial Number
79242171 filed on 09th Jan 2018
Registration Number
5778150 registered on 18th Jun 2019
Correspondent Address
GEOFFREY K PECHIE
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
BIOPALETTE
Research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in th Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; scientific and technological services, namely, research, development, technical advisory services, and information technology services, all relating to genome editing technology; scientific and technological services, namely, research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, and microorganism study, and the study of cells, all with genome editing technology; scientific research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems with genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; information technology services relating to the development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; testing, inspection or research relating to medical treatment or medical technology with genome editing technology; information technology services for testing, inspection or research relating to medical treatment or medical technology with genome editing technology; testing or research relating to genome or gene to which genome editing technology is applied; scientific and medical research and survey in relation to bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; scientific and technical research and development of bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; research and development for the pharmaceutical industry and biotechnology industry with genome editing technology; research and development of biotechnology for others; research and development of genome editing technology for others; development of pharmaceutical preparations and medicines; biotechnology research; research and development in the field of genomics and biotechnology; technical advisory services in the field of genomics and biotechnology; structural and functional analysis of genomes; scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; laboratory research in the field of pharmaceuticals; conducting clinical trials for others in the field of pharmaceuticals; laboratory research in the field of gene expression; research and development services in the field of gene expression systems; research and development services in the field of microorganisms and cells; scientific research services in the field of genetic engineering relating to plants
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [031]
Natural Agricultural Products
Crop seeds; plant seeds; crop seeds produced by genome or gene editing operation; plant seeds produced by genome or gene editing operation; crop seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; plant seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; vegetable seeds for planting produced by genome or gene editing operation; seeds for agricultural purposes; vegetable seeds for planting; seeds for planting; genetically modified seeds including seeds for agricultural purposes, flower seeds, seeds for planting, or vegetable seeds for planting
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Living cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical diagnosis or veterinary diagnosis purposes; pharmaceutical preparations produced by genome or gene editing operation for treatment of genetic diseases; pharmaceutical preparations produced by genome or gene editing operation for modifying human microbiome; chemical reagents for medical purposes produced by genome or gene editing operation; chemical reagents for medical purposes in the field of genome or gene editing operation; cultures of microorganisms for medical or veterinary use produced by genome or gene editing operation; living cells, microorganisms, proteins, peptides, nucleic acid sequences, and combinations thereof for medical or veterinary purposes produced by genome or gene editing operation; biological cells for surgical implantation produced by genome or gene editing operation; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment of genetic diseases; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment of cancer; pharmaceutical and biological preparations, and diagnostic products based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in modifying human microbiome; cultures of microorganisms for medical or veterinary purposes; biological tissue cultures for medical or veterinary purposes * all of the foregoing [ other than those ] produced by genome or gene editing operation *
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemicals for use in industry and science; chemical reagents for use in genetic research other than for medical or veterinary purposes; chemical reagents for use in genetic research in the field of genome or gene editing other than for medical or veterinary purposes; chemical substances produced by genome or gene editing operation for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent for separation and production of gene editing substances for non-medical purposes; biotechnologically-formed genes for use in the manufacture of agricultural seeds produced by genome or gene editing operation; cultures of microorganisms produced by genome or gene editing operation, other than for medical or veterinary use; diagnostic reagents for scientific or research use in the field of genome or gene editing; biotechnologically-formed genes for use in the manufacture of agricultural seeds; cultures of microorganisms, other than for medical or veterinary use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79242171
Mark Type
No Service Mark
Attorney Docket Number
No ISHI.001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Jun 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 18th Mar 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 30th Jul 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 09th Jun 2021 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 06th Jun 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 30th Sep 2020 | CANCELLATION TERMINATED NO. 999999 |
| 24th Sep 2020 | AMENDMENT UNDER SECTION 7 - PROCESSED |
| 24th Sep 2020 | CANCELLATION DENIED NO. 999999 |
| 24th Sep 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 23rd Jul 2020 | AMENDMENT UNDER SECTION 7 - PROCESSED |